Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Fenghuang Zhan

Concepts (553)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
135
2025
2994
9.820
Why?
Gene Expression Regulation, Neoplastic
53
2025
833
3.240
Why?
Drug Resistance, Neoplasm
25
2020
315
3.100
Why?
Gene Expression Profiling
43
2023
1024
2.720
Why?
Cell Proliferation
25
2022
986
2.170
Why?
Plasma Cells
23
2025
220
2.140
Why?
Antineoplastic Agents
29
2020
1173
2.090
Why?
Cell Line, Tumor
46
2025
1403
1.920
Why?
Monoclonal Gammopathy of Undetermined Significance
8
2024
112
1.860
Why?
Neoplastic Stem Cells
7
2020
97
1.630
Why?
Pyrazines
19
2023
187
1.540
Why?
Paraproteinemias
9
2024
71
1.400
Why?
Mice
46
2025
5677
1.400
Why?
Lymphoma, B-Cell
5
2021
49
1.380
Why?
Apoptosis
18
2025
1098
1.360
Why?
Disease Progression
18
2024
829
1.350
Why?
Humans
155
2025
50673
1.340
Why?
Bone Resorption
6
2024
302
1.330
Why?
Boronic Acids
17
2014
182
1.330
Why?
Animals
57
2025
13156
1.220
Why?
Tumor Microenvironment
6
2024
223
1.220
Why?
Neoplasm Proteins
7
2021
321
1.160
Why?
Prognosis
36
2024
1979
1.100
Why?
Osteolysis
4
2022
74
1.080
Why?
B-Lymphocytes
8
2021
171
1.050
Why?
Cell Cycle Proteins
4
2023
163
1.010
Why?
T-Lymphocytes
8
2024
327
0.970
Why?
Hematopoietic Stem Cell Transplantation
6
2024
582
0.960
Why?
Ubiquitination
3
2021
42
0.920
Why?
Proteasome Inhibitors
7
2020
104
0.900
Why?
Signal Transduction
21
2023
1618
0.860
Why?
MicroRNAs
7
2022
345
0.810
Why?
Proteasome Endopeptidase Complex
4
2018
116
0.800
Why?
Antigens, CD
8
2024
223
0.750
Why?
Neoplasms
3
2024
1250
0.730
Why?
Carrier Proteins
3
2017
298
0.660
Why?
CDC2-CDC28 Kinases
3
2015
11
0.640
Why?
Cation Transport Proteins
2
2019
27
0.630
Why?
Up-Regulation
6
2020
447
0.610
Why?
Ubiquitins
2
2016
39
0.610
Why?
Cyclin-Dependent Kinases
2
2010
26
0.610
Why?
Mice, Inbred NOD
5
2020
91
0.600
Why?
Glycolysis
3
2022
69
0.600
Why?
Oligonucleotide Array Sequence Analysis
19
2014
404
0.600
Why?
Waldenstrom Macroglobulinemia
1
2018
40
0.590
Why?
Chromosome Aberrations
6
2023
279
0.580
Why?
Proto-Oncogene Proteins c-akt
5
2023
156
0.580
Why?
Cell Differentiation
9
2023
643
0.580
Why?
Iron
2
2017
121
0.570
Why?
STAT3 Transcription Factor
4
2016
77
0.560
Why?
Pyrimidines
3
2015
191
0.560
Why?
Cell Survival
10
2020
588
0.550
Why?
Killer Cells, Natural
5
2024
107
0.550
Why?
Ascorbic Acid
1
2017
21
0.540
Why?
Pyruvate Kinase
1
2017
7
0.540
Why?
Antineoplastic Combined Chemotherapy Protocols
10
2024
1000
0.540
Why?
RNA Splicing
1
2017
38
0.530
Why?
Protein-Tyrosine Kinases
2
2015
87
0.500
Why?
Down-Regulation
9
2019
339
0.500
Why?
Cyclopentanes
1
2015
10
0.490
Why?
Transplantation, Autologous
5
2024
481
0.490
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2015
68
0.480
Why?
Thalidomide
10
2023
376
0.480
Why?
Aldehyde Dehydrogenase
1
2014
25
0.470
Why?
Osteoclasts
7
2023
427
0.460
Why?
Dexamethasone
7
2024
431
0.460
Why?
Cyclin-Dependent Kinase Inhibitor p27
2
2020
17
0.450
Why?
Female
44
2024
27181
0.440
Why?
Models, Biological
5
2018
721
0.430
Why?
Hematologic Neoplasms
1
2015
99
0.430
Why?
Receptors, Retinoic Acid
2
2013
22
0.420
Why?
Cystatin M
2
2024
19
0.420
Why?
Male
34
2024
25991
0.420
Why?
RNA, Messenger
13
2021
1089
0.420
Why?
Flow Cytometry
8
2018
472
0.410
Why?
B-Cell Maturation Antigen
2
2024
99
0.400
Why?
Antigens, Neoplasm
6
2014
148
0.400
Why?
Glucuronidase
4
2018
48
0.400
Why?
Predictive Value of Tests
5
2016
929
0.370
Why?
Mice, Transgenic
6
2021
540
0.360
Why?
Antibodies, Bispecific
2
2023
89
0.360
Why?
Syndecan-1
6
2017
73
0.360
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
5
0.360
Why?
Arsenicals
1
2010
14
0.350
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
20
0.350
Why?
Oxides
1
2010
18
0.350
Why?
Reverse Transcriptase Polymerase Chain Reaction
12
2015
570
0.340
Why?
Janus Kinase 1
1
2010
16
0.340
Why?
Proto-Oncogene Proteins c-jun
2
2009
77
0.340
Why?
MAP Kinase Kinase 1
1
2010
23
0.340
Why?
Immunotherapy, Adoptive
2
2024
163
0.340
Why?
DNA-Binding Proteins
4
2021
416
0.330
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
80
0.330
Why?
Early Growth Response Protein 1
1
2009
34
0.320
Why?
Lymphoma, Large B-Cell, Diffuse
2
2024
90
0.320
Why?
Transcription Factors
6
2022
566
0.320
Why?
Tretinoin
1
2009
51
0.310
Why?
Oligopeptides
3
2015
95
0.310
Why?
Xenograft Model Antitumor Assays
7
2019
212
0.310
Why?
NF-kappa B
3
2018
313
0.300
Why?
Osteogenesis
5
2023
355
0.300
Why?
Genes, Neoplasm
1
2008
27
0.290
Why?
Tumor Cells, Cultured
6
2020
457
0.290
Why?
Antibodies
3
2024
152
0.290
Why?
Microarray Analysis
3
2018
70
0.290
Why?
Aged
24
2024
9770
0.290
Why?
Chromosomes, Human, Pair 1
4
2023
92
0.280
Why?
Interleukin-6
3
2019
261
0.280
Why?
Immunologic Factors
5
2015
113
0.280
Why?
S-Phase Kinase-Associated Proteins
1
2007
2
0.280
Why?
Neoplasms, Plasma Cell
2
2023
36
0.270
Why?
Tumor Suppressor Protein p53
2
2008
212
0.270
Why?
Small Molecule Libraries
2
2019
67
0.270
Why?
Pyrazoles
2
2020
112
0.270
Why?
Mice, SCID
9
2018
172
0.250
Why?
Protein Kinase Inhibitors
3
2024
205
0.250
Why?
CD8-Positive T-Lymphocytes
3
2024
127
0.250
Why?
Endopeptidase Clp
1
2025
2
0.240
Why?
Risk Factors
11
2018
3731
0.240
Why?
Genomics
2
2023
279
0.240
Why?
Survival Rate
8
2020
907
0.240
Why?
Middle Aged
23
2024
12648
0.230
Why?
Enzyme Inhibitors
4
2019
374
0.230
Why?
Bone Diseases
4
2016
96
0.230
Why?
Polycomb Repressive Complex 2
2
2021
46
0.230
Why?
Bone Marrow
7
2024
360
0.230
Why?
Single-Cell Analysis
1
2025
63
0.230
Why?
Receptors, LDL
1
2024
67
0.220
Why?
Hydroxybenzoates
1
2024
18
0.220
Why?
Propionates
1
2024
22
0.220
Why?
Ferritins
1
2024
30
0.220
Why?
TNF Receptor-Associated Factor 3
2
2022
13
0.220
Why?
Myeloid Progenitor Cells
1
2023
17
0.220
Why?
X-Ray Microtomography
1
2024
80
0.220
Why?
Cholesterol
1
2024
150
0.220
Why?
Melphalan
3
2023
177
0.220
Why?
Histocompatibility Antigens Class I
2
2015
46
0.220
Why?
Antigens, CD19
3
2018
28
0.210
Why?
Neoplasms, Second Primary
1
2024
74
0.210
Why?
Bone Marrow Cells
4
2015
195
0.210
Why?
Membrane Glycoproteins
6
2009
246
0.210
Why?
Cell Transformation, Neoplastic
1
2024
182
0.210
Why?
Proto-Oncogene Proteins c-myc
3
2025
50
0.210
Why?
Genes, myc
3
2019
33
0.210
Why?
Intercellular Signaling Peptides and Proteins
4
2007
102
0.210
Why?
Lymphoma
1
2024
66
0.210
Why?
Bone Diseases, Metabolic
1
2024
74
0.210
Why?
Phenols
1
2024
82
0.210
Why?
Homeostasis
1
2024
204
0.210
Why?
Cluster Analysis
5
2009
216
0.210
Why?
Gene Knockdown Techniques
3
2018
104
0.210
Why?
Bone and Bones
2
2021
481
0.200
Why?
NM23 Nucleoside Diphosphate Kinases
1
2022
4
0.200
Why?
Recurrence
7
2018
663
0.200
Why?
Protein Binding
2
2018
653
0.200
Why?
Neutropenia
1
2023
116
0.200
Why?
Randomized Controlled Trials as Topic
6
2016
569
0.200
Why?
Periodontitis
1
2022
13
0.200
Why?
Antibodies, Monoclonal
3
2013
461
0.200
Why?
In Situ Hybridization, Fluorescence
5
2023
231
0.200
Why?
Reactive Oxygen Species
4
2017
409
0.190
Why?
Case-Control Studies
8
2020
1157
0.190
Why?
Carcinoma, Non-Small-Cell Lung
1
2024
154
0.190
Why?
Protein Stability
2
2020
43
0.190
Why?
Osteoporosis
1
2023
156
0.190
Why?
Kaplan-Meier Estimate
5
2016
463
0.190
Why?
Mitochondria
1
2025
400
0.190
Why?
Adult
20
2024
13636
0.190
Why?
Arthritis, Rheumatoid
1
2022
108
0.190
Why?
Heterogeneous-Nuclear Ribonucleoprotein Group A-B
1
2021
1
0.180
Why?
Nuclear Factor 90 Proteins
1
2021
1
0.180
Why?
RANK Ligand
1
2022
186
0.180
Why?
Oxidative Stress
4
2016
772
0.180
Why?
Ubiquitin-Protein Ligases
2
2020
94
0.180
Why?
Venous Thromboembolism
3
2011
74
0.180
Why?
Phenylpropionates
1
2021
13
0.180
Why?
Hippurates
1
2021
10
0.180
Why?
Gene Expression
4
2017
610
0.180
Why?
Proteolysis
3
2017
96
0.180
Why?
Cell Cycle
4
2010
227
0.180
Why?
Membrane Proteins
3
2017
341
0.180
Why?
Bone Neoplasms
2
2015
178
0.180
Why?
Colonic Neoplasms
1
2022
158
0.180
Why?
Adaptor Proteins, Signal Transducing
1
2021
201
0.170
Why?
Colorectal Neoplasms
2
2022
258
0.170
Why?
Treatment Outcome
12
2020
5294
0.170
Why?
Protease Inhibitors
3
2011
58
0.170
Why?
Cell Movement
2
2015
245
0.170
Why?
Receptors, G-Protein-Coupled
1
2021
49
0.170
Why?
Antigens, CD20
2
2014
6
0.170
Why?
Neoplasm Metastasis
4
2015
230
0.170
Why?
Retrospective Studies
7
2024
6294
0.170
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2015
45
0.170
Why?
Time Factors
8
2021
2948
0.170
Why?
Disease-Free Survival
7
2016
442
0.170
Why?
Evolution, Molecular
1
2021
95
0.170
Why?
Chromosomal Instability
3
2021
16
0.170
Why?
Cytotoxicity, Immunologic
4
2015
57
0.170
Why?
Clinical Trials as Topic
1
2022
488
0.160
Why?
Tumor Suppressor Proteins
2
2019
127
0.160
Why?
Neoplasm Recurrence, Local
1
2024
626
0.160
Why?
DNA, Single-Stranded
1
2020
89
0.160
Why?
NF-E2-Related Factor 2
1
2019
40
0.160
Why?
Oncogene Proteins
1
2019
16
0.160
Why?
Mitosis
3
2015
88
0.160
Why?
Carcinoma, Neuroendocrine
1
2019
23
0.160
Why?
Transplantation, Heterologous
2
2017
73
0.150
Why?
rab GTP-Binding Proteins
1
2019
37
0.150
Why?
Healthcare Disparities
1
2022
280
0.150
Why?
Receptors, Interleukin-6
1
2018
22
0.150
Why?
Neovascularization, Pathologic
3
2009
155
0.150
Why?
Drug Tolerance
1
2018
60
0.150
Why?
Pyridines
1
2019
132
0.150
Why?
Blotting, Western
3
2015
577
0.150
Why?
Lung Neoplasms
1
2024
599
0.150
Why?
Drug Therapy, Combination
2
2017
388
0.140
Why?
beta Catenin
2
2015
96
0.140
Why?
Mice, Knockout
4
2023
842
0.140
Why?
M Phase Cell Cycle Checkpoints
1
2017
4
0.140
Why?
Hydroxamic Acids
2
2014
37
0.140
Why?
Aerobiosis
1
2017
14
0.140
Why?
Microfilament Proteins
1
2017
42
0.140
Why?
Onium Compounds
1
2016
13
0.140
Why?
Thyroid Hormones
1
2017
20
0.140
Why?
Calcium-Binding Proteins
1
2017
55
0.130
Why?
Organophosphorus Compounds
1
2016
15
0.130
Why?
Deoxyglucose
1
2016
36
0.130
Why?
Histone Deacetylase Inhibitors
2
2014
56
0.130
Why?
Survival Analysis
6
2020
661
0.130
Why?
Inhibitor of Apoptosis Proteins
3
2015
21
0.130
Why?
Pancreatic Neoplasms
1
2019
206
0.130
Why?
Gene Deletion
2
2008
261
0.130
Why?
Syndecans
3
2006
35
0.130
Why?
Aged, 80 and over
7
2021
3244
0.130
Why?
RNA Interference
2
2015
179
0.130
Why?
Cell Death
1
2016
175
0.130
Why?
Ribosomal Proteins
1
2016
24
0.130
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2016
45
0.130
Why?
Proto-Oncogene Proteins
2
2009
150
0.130
Why?
Proteoglycans
3
2006
81
0.130
Why?
Macrophages
2
2022
365
0.120
Why?
Oncolytic Virotherapy
1
2015
18
0.120
Why?
Gene Dosage
2
2013
74
0.120
Why?
Cell Adhesion Molecules
1
2015
86
0.120
Why?
Polysaccharides
1
2015
51
0.120
Why?
Core Binding Factor Alpha 1 Subunit
1
2015
44
0.120
Why?
Receptors, Transferrin
1
2015
16
0.120
Why?
Side-Population Cells
1
2015
3
0.120
Why?
Lentivirus
1
2015
17
0.120
Why?
Serine Endopeptidases
2
2006
51
0.120
Why?
Retinal Dehydrogenase
1
2014
10
0.120
Why?
Receptors, Cell Surface
1
2015
119
0.120
Why?
Adenine
1
2015
31
0.120
Why?
Caspase 3
2
2022
93
0.120
Why?
Serum
1
2014
32
0.110
Why?
Cell Lineage
1
2014
83
0.110
Why?
Translocation, Genetic
4
2021
237
0.110
Why?
Proto-Oncogene Proteins c-kit
1
2014
34
0.110
Why?
Superoxide Dismutase
1
2014
116
0.110
Why?
Tumor Burden
3
2020
130
0.110
Why?
Piperidines
1
2015
99
0.110
Why?
Cyclins
3
2015
38
0.110
Why?
HLA Antigens
1
2014
53
0.110
Why?
Alkaline Phosphatase
2
2011
94
0.110
Why?
Glycoproteins
1
2014
116
0.110
Why?
Repressor Proteins
4
2015
149
0.110
Why?
11-beta-Hydroxysteroid Dehydrogenase Type 2
1
2013
12
0.110
Why?
Leukemia, Plasma Cell
1
2013
32
0.110
Why?
Lactate Dehydrogenases
1
2013
1
0.110
Why?
Phenotype
4
2009
739
0.110
Why?
Genome, Human
2
2021
109
0.100
Why?
Intercellular Adhesion Molecule-1
1
2013
61
0.100
Why?
Follow-Up Studies
5
2024
2246
0.100
Why?
Dose-Response Relationship, Drug
4
2020
1376
0.100
Why?
Scavenger Receptors, Class A
1
2013
39
0.100
Why?
Disease Models, Animal
4
2020
1440
0.100
Why?
Leukemia
1
2013
65
0.100
Why?
bcl-X Protein
1
2013
53
0.100
Why?
Heat-Shock Proteins
1
2013
99
0.100
Why?
RNA, Small Interfering
2
2010
209
0.100
Why?
RNA, Neoplasm
3
2007
44
0.100
Why?
Forkhead Transcription Factors
2
2023
109
0.100
Why?
Clinical Trials, Phase III as Topic
2
2012
47
0.100
Why?
Cysteine Proteinase Inhibitors
1
2011
22
0.090
Why?
Drug Screening Assays, Antitumor
3
2020
132
0.090
Why?
Activated Protein C Resistance
1
2011
10
0.090
Why?
Factor V
1
2011
11
0.090
Why?
Protein Isoforms
2
2009
116
0.090
Why?
Acetylcysteine
1
2011
101
0.090
Why?
Glucocorticoids
1
2013
235
0.090
Why?
Interferon Regulatory Factor-1
1
2010
14
0.090
Why?
Cell Growth Processes
1
2010
22
0.090
Why?
HLA-A Antigens
2
2007
10
0.090
Why?
Cells, Cultured
6
2015
1578
0.080
Why?
Gene Silencing
2
2007
114
0.080
Why?
Alleles
2
2021
254
0.080
Why?
Epigenesis, Genetic
2
2023
372
0.080
Why?
Thrombosis
1
2012
250
0.080
Why?
Immunophenotyping
5
2010
106
0.080
Why?
K562 Cells
3
2016
40
0.080
Why?
Microtubule-Associated Proteins
1
2009
66
0.080
Why?
Recombinant Proteins
1
2010
479
0.080
Why?
Bone Remodeling
1
2010
149
0.080
Why?
Chromosome Mapping
2
2006
153
0.080
Why?
Thromboembolism
1
2009
55
0.080
Why?
Neoplasm Staging
3
2024
743
0.080
Why?
Mutation
3
2021
1280
0.080
Why?
Lymphocyte Subsets
1
2008
14
0.070
Why?
Receptors, Immunologic
1
2008
35
0.070
Why?
ras Proteins
2
2020
65
0.070
Why?
Angiogenesis Inhibitors
1
2009
183
0.070
Why?
Neoplasm Transplantation
2
2020
83
0.070
Why?
G2 Phase Cell Cycle Checkpoints
2
2020
9
0.070
Why?
Patient Selection
1
2009
258
0.070
Why?
Adoptive Transfer
1
2007
29
0.070
Why?
Protein Tyrosine Phosphatases
1
2007
23
0.070
Why?
Genes, abl
1
2007
2
0.070
Why?
Gene Expression Regulation
2
2022
952
0.070
Why?
Breast Neoplasms
2
2007
1203
0.070
Why?
HEK293 Cells
2
2019
209
0.070
Why?
Cancer Vaccines
1
2007
80
0.070
Why?
JNK Mitogen-Activated Protein Kinases
1
2007
71
0.070
Why?
Drug Evaluation, Preclinical
2
2021
144
0.070
Why?
Caspases
1
2007
103
0.070
Why?
Cyclin D
1
2006
18
0.070
Why?
Chromosome Banding
1
2006
18
0.060
Why?
Proportional Hazards Models
2
2024
416
0.060
Why?
Models, Genetic
1
2006
172
0.060
Why?
Palatine Tonsil
2
2003
11
0.060
Why?
Peptides
1
2007
220
0.060
Why?
DNA Damage
1
2008
300
0.060
Why?
Maf Transcription Factors, Large
1
2005
1
0.060
Why?
Gene Expression Regulation, Enzymologic
1
2007
178
0.060
Why?
Data Interpretation, Statistical
1
2006
163
0.060
Why?
Doxorubicin
2
2018
236
0.060
Why?
Protein Kinases
1
2005
70
0.060
Why?
Cyclin D1
1
2005
52
0.060
Why?
Antibody Formation
1
2005
50
0.060
Why?
Protein Biosynthesis
2
2003
232
0.060
Why?
Mice, Inbred C57BL
2
2021
1801
0.060
Why?
Cystadenocarcinoma, Serous
1
2004
71
0.060
Why?
Papillomaviridae
1
2005
103
0.060
Why?
Base Sequence
3
2015
644
0.060
Why?
Carcinoma, Papillary
1
2004
47
0.060
Why?
Transfection
2
2020
356
0.060
Why?
Transcription, Genetic
1
2005
362
0.060
Why?
Mice, Inbred BALB C
2
2019
294
0.060
Why?
Drug Synergism
2
2014
152
0.060
Why?
Genetic Predisposition to Disease
1
2007
511
0.050
Why?
Jurkat Cells
2
2014
27
0.050
Why?
Zebrafish Proteins
1
2003
21
0.050
Why?
Extracellular Matrix Proteins
1
2004
68
0.050
Why?
Adipogenesis
1
2024
49
0.050
Why?
Steroids
1
2024
57
0.050
Why?
Ovariectomy
1
2024
115
0.050
Why?
PPAR gamma
1
2024
65
0.050
Why?
Sequence Analysis, RNA
1
2024
89
0.050
Why?
Integrin beta Chains
1
2023
13
0.050
Why?
Integrins
1
2023
30
0.050
Why?
Chromosomes, Human, Pair 13
1
2003
34
0.050
Why?
Oxidative Phosphorylation
1
2023
41
0.050
Why?
Receptors, Fibroblast Growth Factor
1
2002
9
0.050
Why?
Cytogenetic Analysis
1
2023
74
0.050
Why?
Chromosomes, Human, Pair 4
1
2002
30
0.050
Why?
Chromosomes, Human, Pair 14
1
2002
66
0.050
Why?
Chromosome Deletion
1
2023
134
0.050
Why?
Macrophage Activation
1
2022
25
0.050
Why?
Oncogene Proteins, Fusion
1
2002
57
0.050
Why?
Porphyromonas gingivalis
1
2022
14
0.050
Why?
Geography
1
2022
60
0.050
Why?
Computational Biology
2
2020
214
0.050
Why?
Chromatin
1
2023
135
0.050
Why?
Uterine Cervical Neoplasms
1
2005
276
0.050
Why?
Diploidy
3
2007
26
0.050
Why?
Inflammasomes
1
2022
62
0.050
Why?
DNA, Neoplasm
1
2002
144
0.050
Why?
Models, Animal
2
2015
226
0.050
Why?
Mutation Rate
1
2021
35
0.040
Why?
DNA Primers
2
2015
207
0.040
Why?
Clone Cells
1
2021
73
0.040
Why?
Proteins
1
2003
343
0.040
Why?
Genes, Tumor Suppressor
1
2021
73
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
67
0.040
Why?
HCT116 Cells
1
2020
21
0.040
Why?
Ovarian Neoplasms
1
2004
449
0.040
Why?
DNA Copy Number Variations
1
2021
109
0.040
Why?
Cytokines
3
2009
607
0.040
Why?
Wnt Signaling Pathway
1
2021
85
0.040
Why?
Double-Blind Method
2
2014
710
0.040
Why?
3' Untranslated Regions
1
2020
53
0.040
Why?
Immunohistochemistry
3
2009
958
0.040
Why?
Software
1
2002
276
0.040
Why?
DNA
1
2023
536
0.040
Why?
Gene Knockout Techniques
1
2019
39
0.040
Why?
Genetic Variation
1
2020
208
0.040
Why?
Drug Discovery
1
2020
85
0.040
Why?
Crystallography, X-Ray
1
2019
145
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
170
0.040
Why?
Protein Phosphatase 2
1
2019
4
0.040
Why?
Multivariate Analysis
1
2021
584
0.040
Why?
G1 Phase
1
2019
13
0.040
Why?
Protein Conformation
1
2019
165
0.040
Why?
Enzyme Activators
1
2019
8
0.040
Why?
Immunotherapy
1
2021
236
0.040
Why?
Mice, Nude
1
2019
248
0.040
Why?
Antibody-Dependent Cell Cytotoxicity
2
2009
13
0.040
Why?
Structure-Activity Relationship
1
2020
395
0.040
Why?
Wnt Proteins
2
2013
97
0.040
Why?
DNA Methylation
1
2023
549
0.040
Why?
TOR Serine-Threonine Kinases
1
2019
78
0.040
Why?
Phosphorylation
1
2020
526
0.040
Why?
Drug Resistance
1
2018
65
0.040
Why?
Autophagy
1
2020
170
0.040
Why?
Cross-Sectional Studies
1
2022
1613
0.030
Why?
Cell Cycle Checkpoints
1
2017
29
0.030
Why?
Chronic Disease
1
2019
576
0.030
Why?
Cell Hypoxia
1
2016
82
0.030
Why?
Biological Transport
1
2016
170
0.030
Why?
Endoplasmic Reticulum Stress
1
2016
41
0.030
Why?
Models, Statistical
2
2008
226
0.030
Why?
Drug Interactions
1
2016
207
0.030
Why?
Cell Line
2
2013
1001
0.030
Why?
Mice, Inbred ICR
1
2016
22
0.030
Why?
Transcriptional Activation
1
2016
121
0.030
Why?
Microscopy, Electron, Transmission
1
2015
73
0.030
Why?
Pharmacogenetics
2
2006
50
0.030
Why?
Vidarabine
1
2015
9
0.030
Why?
Mitoxantrone
1
2015
8
0.030
Why?
Reoviridae
1
2015
25
0.030
Why?
Antibodies, Monoclonal, Murine-Derived
1
2015
45
0.030
Why?
Vincristine
1
2015
82
0.030
Why?
China
1
2015
91
0.030
Why?
Vaccination
2
2007
277
0.030
Why?
Prednisone
1
2015
101
0.030
Why?
Ligands
1
2015
203
0.030
Why?
Molecular Targeted Therapy
1
2016
122
0.030
Why?
Glutathione Peroxidase
1
2014
23
0.030
Why?
Cyclin B
1
2014
5
0.030
Why?
Risk Assessment
2
2009
1271
0.030
Why?
Microscopy, Fluorescence
1
2015
161
0.030
Why?
Cyclophosphamide
1
2015
168
0.030
Why?
Disulfiram
1
2014
13
0.030
Why?
CDC2 Protein Kinase
1
2014
17
0.030
Why?
Portraits as Topic
1
2014
2
0.030
Why?
Glucose
1
2016
341
0.030
Why?
Membrane Potential, Mitochondrial
1
2014
36
0.030
Why?
Antigens, Differentiation, T-Lymphocyte
1
2013
9
0.030
Why?
Chemotherapy, Adjuvant
1
2014
121
0.030
Why?
Lectins, C-Type
1
2013
30
0.030
Why?
Veratrum Alkaloids
1
2013
5
0.030
Why?
Multidrug Resistance-Associated Proteins
1
2013
16
0.030
Why?
Isoxazoles
1
2013
14
0.030
Why?
G1 Phase Cell Cycle Checkpoints
1
2013
16
0.030
Why?
Glutathione
1
2014
299
0.030
Why?
Gene Expression Regulation, Leukemic
1
2013
29
0.030
Why?
Hedgehog Proteins
1
2013
31
0.030
Why?
Sulfones
1
2013
24
0.030
Why?
Itraconazole
1
2013
41
0.030
Why?
Peptide Library
1
2013
16
0.030
Why?
Receptors, Glucocorticoid
1
2013
31
0.030
Why?
Azacitidine
1
2013
34
0.030
Why?
Receptors, IgG
1
2013
23
0.030
Why?
Oxidants
1
2013
54
0.030
Why?
ADP-ribosyl Cyclase
2
2003
5
0.030
Why?
Epitopes
1
2013
61
0.030
Why?
Hydrocortisone
1
2013
110
0.030
Why?
p38 Mitogen-Activated Protein Kinases
1
2013
92
0.030
Why?
MAP Kinase Signaling System
1
2013
117
0.030
Why?
Prospective Studies
2
2010
2395
0.030
Why?
Hydrogen Peroxide
1
2013
113
0.020
Why?
Histone Deacetylases
1
2013
51
0.020
Why?
Proto-Oncogene Proteins c-bcl-2
1
2013
128
0.020
Why?
Radiation, Ionizing
1
2013
99
0.020
Why?
Osteoblasts
2
2006
463
0.020
Why?
Transcriptome
1
2014
314
0.020
Why?
Clinical Trials, Phase II as Topic
1
2012
46
0.020
Why?
Viper Venoms
1
2011
7
0.020
Why?
Protein C
1
2011
18
0.020
Why?
Risk
1
2011
326
0.020
Why?
Bone Density Conservation Agents
1
2010
74
0.020
Why?
Diphosphonates
1
2010
90
0.020
Why?
Databases as Topic
1
2009
37
0.020
Why?
Parathyroid Hormone
1
2010
149
0.020
Why?
Lymphocytes
1
2010
154
0.020
Why?
Cytoskeleton
1
2008
41
0.020
Why?
Genotype
1
2009
532
0.020
Why?
Twins
1
2007
20
0.020
Why?
STAT Transcription Factors
1
2007
8
0.020
Why?
Antibodies, Monoclonal, Humanized
1
2009
225
0.020
Why?
Cytological Techniques
1
2007
14
0.020
Why?
NF-kappa B p52 Subunit
1
2007
6
0.020
Why?
NF-kappa B p50 Subunit
1
2007
16
0.020
Why?
I-kappa B Kinase
1
2007
20
0.020
Why?
Karyotyping
1
2007
65
0.020
Why?
T-Lymphocytes, Cytotoxic
1
2007
63
0.020
Why?
HLA-A2 Antigen
1
2007
11
0.020
Why?
Benzamides
1
2007
50
0.020
Why?
Antigen Presentation
1
2007
25
0.020
Why?
Remission Induction
1
2007
209
0.020
Why?
Polysaccharide-Lyases
1
2007
6
0.020
Why?
Leukocytes, Mononuclear
1
2007
119
0.020
Why?
Plasmids
1
2007
164
0.020
Why?
Tissue Culture Techniques
1
2007
37
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2007
231
0.020
Why?
Interferon-gamma
1
2007
176
0.020
Why?
Enzyme Activation
1
2007
270
0.020
Why?
Multigene Family
1
2006
54
0.020
Why?
Anticoagulants
1
2009
254
0.020
Why?
Piperazines
1
2007
120
0.020
Why?
Neoplasms, Experimental
1
2007
111
0.020
Why?
Antineoplastic Agents, Hormonal
1
2006
49
0.020
Why?
Diagnosis, Differential
1
2010
1034
0.020
Why?
Dendritic Cells
1
2007
135
0.020
Why?
Incidence
1
2009
1036
0.020
Why?
Polymerase Chain Reaction
1
2007
451
0.020
Why?
Receptors, Estrogen
1
2007
132
0.020
Why?
Chromosomes, Human
1
2006
39
0.020
Why?
Gelatinases
1
2006
32
0.020
Why?
Endopeptidases
1
2006
65
0.020
Why?
Rabbits
1
2006
372
0.020
Why?
Coculture Techniques
1
2006
142
0.020
Why?
Combined Modality Therapy
1
2007
642
0.020
Why?
Cyclin D3
1
2005
5
0.020
Why?
Cyclin D2
1
2005
20
0.010
Why?
Trisomy
1
2005
27
0.010
Why?
Adipocytes
1
2006
126
0.010
Why?
Stem Cells
1
2006
165
0.010
Why?
Oligonucleotide Probes
1
2004
20
0.010
Why?
Epithelium
1
2004
66
0.010
Why?
Molecular Sequence Data
1
2006
782
0.010
Why?
Endothelium, Vascular
1
2006
252
0.010
Why?
Ovary
1
2004
114
0.010
Why?
Endothelial Cells
1
2006
258
0.010
Why?
Databases, Factual
1
2007
676
0.010
Why?
Bacterial Proteins
1
2007
367
0.010
Why?
RNA, Complementary
1
2003
2
0.010
Why?
Autocrine Communication
1
2003
8
0.010
Why?
Paracrine Communication
1
2003
12
0.010
Why?
Metaphase
1
2003
45
0.010
Why?
Receptor, Fibroblast Growth Factor, Type 3
1
2002
18
0.010
Why?
Cell Separation
1
2003
93
0.010
Why?
Biopsy
1
2005
589
0.010
Why?
Melanoma-Specific Antigens
1
2002
3
0.010
Why?
NAD+ Nucleosidase
1
2002
3
0.010
Why?
Antigens, Differentiation
1
2002
17
0.010
Why?
Cell Communication
1
2003
70
0.010
Why?
Gene Expression Regulation, Developmental
1
2003
135
0.010
Why?
Cohort Studies
1
2006
1455
0.010
Why?
Immunoglobulins
1
2002
81
0.010
Why?
Database Management Systems
1
2002
28
0.010
Why?
Reproducibility of Results
1
2005
1199
0.010
Why?
Logistic Models
1
2003
902
0.010
Why?
Magnetic Resonance Imaging
1
2003
1556
0.010
Why?
Zhan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description